NO851772L - Fremgangsmaate til fremstilling av 2-amino-3-etoksy-krbonylamino-6-(p-fluor-benzylamino)-pyridin-glukonat samt injiserbare opploesninger inneholdende dette stoff. - Google Patents
Fremgangsmaate til fremstilling av 2-amino-3-etoksy-krbonylamino-6-(p-fluor-benzylamino)-pyridin-glukonat samt injiserbare opploesninger inneholdende dette stoff.Info
- Publication number
- NO851772L NO851772L NO851772A NO851772A NO851772L NO 851772 L NO851772 L NO 851772L NO 851772 A NO851772 A NO 851772A NO 851772 A NO851772 A NO 851772A NO 851772 L NO851772 L NO 851772L
- Authority
- NO
- Norway
- Prior art keywords
- amino
- fluoro
- pyridine
- benzylamino
- gluconate
- Prior art date
Links
- 229940050410 gluconate Drugs 0.000 title claims description 13
- 238000002360 preparation method Methods 0.000 title claims description 7
- 239000000126 substance Substances 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 21
- 235000012208 gluconic acid Nutrition 0.000 claims description 20
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 19
- 239000000174 gluconic acid Substances 0.000 claims description 19
- JUUFBMODXQKSTD-UHFFFAOYSA-N N-[2-amino-6-[(4-fluorophenyl)methylamino]-3-pyridinyl]carbamic acid ethyl ester Chemical compound N1=C(N)C(NC(=O)OCC)=CC=C1NCC1=CC=C(F)C=C1 JUUFBMODXQKSTD-UHFFFAOYSA-N 0.000 claims description 18
- 239000002904 solvent Substances 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 14
- -1 2-amino-3-ethoxycarbonyl-amino-6-(p-fluoro-benzylamino)-pyridine-gluconate Chemical compound 0.000 claims description 11
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 claims description 11
- 229920001223 polyethylene glycol Polymers 0.000 claims description 9
- 239000002202 Polyethylene glycol Substances 0.000 claims description 6
- 150000007524 organic acids Chemical class 0.000 claims description 3
- DLLBDGNKUZZOKZ-UHFFFAOYSA-N ethyl 2,4-diamino-6-[(4-fluorophenyl)methylamino]pyridine-3-carboxylate Chemical compound N1=C(N)C(C(=O)OCC)=C(N)C=C1NCC1=CC=C(F)C=C1 DLLBDGNKUZZOKZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 239000004698 Polyethylene Substances 0.000 description 6
- 229920000573 polyethylene Polymers 0.000 description 6
- KTUKTXYTLNEYHO-IFWQJVLJSA-N ethyl n-[2-amino-6-[(4-fluorophenyl)methylamino]pyridin-3-yl]carbamate;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.N1=C(N)C(NC(=O)OCC)=CC=C1NCC1=CC=C(F)C=C1 KTUKTXYTLNEYHO-IFWQJVLJSA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- AQIXEPGDORPWBJ-UHFFFAOYSA-N pentan-3-ol Chemical compound CCC(O)CC AQIXEPGDORPWBJ-UHFFFAOYSA-N 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- CTPDSKVQLSDPLC-UHFFFAOYSA-N 2-(oxolan-2-ylmethoxy)ethanol Chemical compound OCCOCC1CCCO1 CTPDSKVQLSDPLC-UHFFFAOYSA-N 0.000 description 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- JRTMNNRREQDVJG-UHFFFAOYSA-L disodium propan-2-one sulfinato sulfite Chemical compound [Na+].[Na+].CC(C)=O.[O-]S(=O)OS([O-])=O JRTMNNRREQDVJG-UHFFFAOYSA-L 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- WBAZQELGBFQHPE-UHFFFAOYSA-N ethyl n-[2-amino-6-[(4-fluorophenyl)methylamino]pyridin-3-yl]carbamate;hydron;chloride Chemical compound Cl.N1=C(N)C(NC(=O)OCC)=CC=C1NCC1=CC=C(F)C=C1 WBAZQELGBFQHPE-UHFFFAOYSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/10—Polyhydroxy carboxylic acids
- C07C59/105—Polyhydroxy carboxylic acids having five or more carbon atoms, e.g. aldonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843416609 DE3416609A1 (de) | 1984-05-05 | 1984-05-05 | 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)- pyridin-gluconat und pharmazeutische zubereitungen, die diese substanz enthalten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO851772L true NO851772L (no) | 1985-11-06 |
Family
ID=6235001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO851772A NO851772L (no) | 1984-05-05 | 1985-05-03 | Fremgangsmaate til fremstilling av 2-amino-3-etoksy-krbonylamino-6-(p-fluor-benzylamino)-pyridin-glukonat samt injiserbare opploesninger inneholdende dette stoff. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4673666A (ja) |
| EP (1) | EP0160865B1 (ja) |
| JP (1) | JPS60239469A (ja) |
| KR (1) | KR850008678A (ja) |
| AT (1) | ATE33638T1 (ja) |
| AU (1) | AU4194385A (ja) |
| BG (1) | BG44537A3 (ja) |
| CA (1) | CA1263398A (ja) |
| CS (1) | CS248743B2 (ja) |
| DD (1) | DD236927A5 (ja) |
| DE (2) | DE3416609A1 (ja) |
| DK (1) | DK157016C (ja) |
| ES (1) | ES542817A0 (ja) |
| FI (1) | FI80443C (ja) |
| GR (1) | GR851065B (ja) |
| HU (1) | HU193753B (ja) |
| IE (1) | IE57766B1 (ja) |
| IL (1) | IL75086A (ja) |
| MC (1) | MC1651A1 (ja) |
| NO (1) | NO851772L (ja) |
| PL (1) | PL253202A1 (ja) |
| PT (1) | PT80386B (ja) |
| SU (1) | SU1398772A3 (ja) |
| YU (1) | YU71785A (ja) |
| ZA (1) | ZA853351B (ja) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2733151B1 (fr) * | 1995-04-20 | 1997-05-23 | Seppic Sa | Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines |
| US6689370B1 (en) | 1995-04-20 | 2004-02-10 | Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) | Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
| US6117432A (en) * | 1995-04-20 | 2000-09-12 | Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) | Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
| US6821995B1 (en) | 1999-12-01 | 2004-11-23 | Duke University | Method of treating batten disease |
| DE10327674A1 (de) * | 2003-06-20 | 2005-01-05 | Awd.Pharma Gmbh & Co. Kg | Injizierbare Darreichungsform von Flupirtin |
| US20080279930A1 (en) * | 2007-05-07 | 2008-11-13 | Bernd Terhaag | Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof |
| EP2350009B1 (en) * | 2008-06-09 | 2016-03-16 | TEVA GmbH | Sulfonate salts of flupirtine |
| EA020545B1 (ru) | 2008-06-09 | 2014-12-30 | Авд. Фарма Гмбх Унд Ко. Кг | Соли карбоновой кислоты 2-амино-3-карбэтоксиамино-6-(4-фторбензиламино)пиридина |
| DE102010030053A1 (de) | 2010-06-14 | 2011-12-15 | Awd.Pharma Gmbh & Co.Kg | Injizierbare Darreichungsform von Flupirtin |
| WO2012004391A1 (en) | 2010-07-09 | 2012-01-12 | K.H.S. Pharma Holding Gmbh | Process for the preparation of flupirtine maleate |
| CN102850265B (zh) * | 2011-06-29 | 2015-11-25 | 陈小花 | 一种氟吡汀偶联物及其制备方法和用途 |
| CN102351786A (zh) * | 2011-11-01 | 2012-02-15 | 东南大学 | 一种氟吡汀丙二酸盐及其制备方法 |
| CN103910674B (zh) * | 2013-12-19 | 2015-12-02 | 天津红日药业股份有限公司 | 用于马来酸氟吡汀分析中的参比化合物 |
| CN104974087A (zh) * | 2015-01-30 | 2015-10-14 | 吉林修正药业新药开发有限公司 | 一种氟吡汀二聚体的合成方法 |
| DE102017007385A1 (de) | 2017-08-02 | 2019-02-07 | Christoph Hoock | Maleatfreie feste Arzneimittelformen |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3133519A1 (de) * | 1980-09-13 | 1982-06-09 | Degussa Ag, 6000 Frankfurt | "2-amino-3-carbethoxyamino-6-(p-fluor-benzylamino)-pyridin-maleat" |
| US4481205A (en) * | 1980-09-13 | 1984-11-06 | Degussa Aktiengesellschaft | 2-Amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)-pyridine-maleate |
-
1984
- 1984-05-05 DE DE19843416609 patent/DE3416609A1/de not_active Withdrawn
-
1985
- 1985-04-19 EP EP85104746A patent/EP0160865B1/de not_active Expired
- 1985-04-19 DE DE8585104746T patent/DE3562242D1/de not_active Expired
- 1985-04-19 AT AT85104746T patent/ATE33638T1/de not_active IP Right Cessation
- 1985-04-26 SU SU853884101A patent/SU1398772A3/ru active
- 1985-04-29 YU YU00717/85A patent/YU71785A/xx unknown
- 1985-04-30 CS CS853157A patent/CS248743B2/cs unknown
- 1985-05-01 US US06/729,413 patent/US4673666A/en not_active Expired - Lifetime
- 1985-05-02 DD DD85275890A patent/DD236927A5/de unknown
- 1985-05-02 GR GR851065A patent/GR851065B/el unknown
- 1985-05-02 DK DK198785A patent/DK157016C/da not_active IP Right Cessation
- 1985-05-03 IL IL75086A patent/IL75086A/xx unknown
- 1985-05-03 NO NO851772A patent/NO851772L/no unknown
- 1985-05-03 PT PT80386A patent/PT80386B/pt unknown
- 1985-05-03 BG BG070073A patent/BG44537A3/xx unknown
- 1985-05-03 HU HU851691A patent/HU193753B/hu unknown
- 1985-05-03 MC MC851765A patent/MC1651A1/xx unknown
- 1985-05-03 FI FI851752A patent/FI80443C/fi not_active IP Right Cessation
- 1985-05-03 AU AU41943/85A patent/AU4194385A/en not_active Abandoned
- 1985-05-03 ES ES542817A patent/ES542817A0/es active Granted
- 1985-05-03 ZA ZA853351A patent/ZA853351B/xx unknown
- 1985-05-03 PL PL25320285A patent/PL253202A1/xx unknown
- 1985-05-03 CA CA000480723A patent/CA1263398A/en not_active Expired
- 1985-05-03 IE IE1117/85A patent/IE57766B1/en not_active IP Right Cessation
- 1985-05-04 KR KR1019850003047A patent/KR850008678A/ko not_active Application Discontinuation
- 1985-05-07 JP JP60095714A patent/JPS60239469A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO851772L (no) | Fremgangsmaate til fremstilling av 2-amino-3-etoksy-krbonylamino-6-(p-fluor-benzylamino)-pyridin-glukonat samt injiserbare opploesninger inneholdende dette stoff. | |
| NO127359B (ja) | ||
| NO171765B (no) | Fremgangsmaate for fremstilling av opploesninger av melkesyresalter av piperazinylkinolon- og piperazinylazakinolonkarboksylsyrer | |
| NO163314B (no) | Fremgangsmaate for fremstilling av stabile, vandige loesninger av oxicamderivater. | |
| DK166320B (da) | Eddikesyreesteren af haloperidol, fremgangsmaade til fremstilling heraf og farmaceutiske kompositioner deraf | |
| JP3835815B2 (ja) | エンロフロキサシンの注射用もしくは注入用溶液 | |
| US4769381A (en) | Nicorandil-containing preparation for injection | |
| NO121950B (ja) | ||
| DK246180A (da) | Fremgangsmaade til fremstilling af paromomycinderivater | |
| NO752078L (ja) | ||
| US3309367A (en) | Derivatives of benzamidobenzanilide | |
| NO138026B (no) | Analogifremgangsm}te til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner | |
| NO127920B (ja) | ||
| JP2003514779A5 (ja) | ||
| EP1504755A1 (en) | Lyophilization product | |
| US3957758A (en) | 6-acyl derivatives of aminopenicillanic acid | |
| CA1075230A (en) | Process for preparing solid sodium amoxycillin | |
| EP0268396B1 (en) | 4-(benzoyl)thiophene(or furan)-sulfonamide and derivatives thereof for the topical treatment of elevated intraocular pressures | |
| HU204700B (en) | Process for producing aqueous compositions comprising piperidinyl cyclopentylheptenoic acid derivatives | |
| JPS5821624B2 (ja) | ３ カンジフエニルアミン − ユウドウタイノ セイホウ | |
| JPS58966A (ja) | 抗菌性ナフチリジンおよびキノリン化合物の塩 | |
| KR790000943B1 (ko) | 복소환 화합물의 제조방법 | |
| NO143534B (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av oxatiino(1,4)(2,3-c)pyrrol | |
| US3860608A (en) | 3-aminoalkyloxyindoles | |
| FI72651C (fi) | Foerfarande foer framstaellning av en laongtidsverkande injektionsloesning av sulfametazin. |